PHAT Stock-Based Compensation
Phathom Pharmaceuticals Inc · Stock-Based Compensation
PHAT Stock-Based Compensation
Latest reported$6.71Mperiod ending
PHAT Quarterly Stock-Based Comp ($0.00 → $6.71M)
Quarterly stock-based compensation
High-resolution chart · PNG
PHAT stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 6,712,000 | |
| 5,534,000 | |
| 5,610,000 | |
| 9,297,000 | |
| 8,272,000 | |
| 5,540,000 | |
| 6,687,000 | |
| 5,635,000 | |
| 6,099,000 | |
| 5,626,000 | |
| 24,584,000 | |
| 6,140,000 | |
| 7,253,000 | |
| 7,048,000 | |
| 6,657,000 | |
| 5,816,000 | |
| 5,885,000 | |
| 5,775,000 | |
| 4,338,000 | |
| 4,419,000 | |
| 4,237,000 | |
| 3,818,000 | |
| 2,379,000 | |
| 2,070,000 | |
| 828,000 | |
| 563,000 | |
| 340,000 | |
| 37,000 | |
| 29,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |